GlassScriptPhysician profile
Charles J Kilo
NPI 1306886635
$49,713.59
in general payments reported to CMS, 2019-2025
64 companies · $2,698 in 2025
The $2,698 reported for 2025 was more than what 81% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $11K · 2021: $4,109 · 2022: $3,366 · 2023: $3,581 · 2024: $2,757 · 2025: $2,698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,941 · Education: $95.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,941.13 |
| Education | $95.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $26,575.44 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $3,414.88 | 2019-2025 | Ozempic, Rybelsus, Tresiba |
| Sanofi-Aventis U.S. LLC | $2,026.66 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,682.68 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Lilly USA, LLC | $1,670.75 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $1,523.52 | 2019-2024 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $1,439.11 | 2019-2025 | Repatha, Otezla, Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $974.09 | 2021-2025 | |
| Currax Pharmaceuticals LLC | $892.37 | 2020-2025 | Contrave, Onzetra Xsail, Nexlizet |
| Pfizer INC. | $823.08 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $695.56 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Xeris Pharmaceuticals, INC. | $693.07 | 2020-2025 | Gvoke Hypopen |
| Abbott Laboratories | $653.12 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Amarin Pharma, INC. | $635.77 | 2019-2022 | |
| Mannkind Corporation | $567.25 | 2019-2025 | Afrezza |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $533.96 | 2020-2025 | |
| Dexcom, INC. | $412.93 | 2019-2025 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $412.06 | 2020-2025 | Korlym |
| Insulet Corporation | $394.68 | 2019-2025 | Omnipod |
| Glaxosmithkline, LLC. | $292.57 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Exact Sciences Corporation | $247.80 | 2023-2025 | Cologuard Collection Kit |
| Tandem Diabetes Care, INC. | $242.11 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Esperion Therapeutics, INC. | $238.22 | 2020-2025 | Nexletol |
| Zealand Pharma US, INC. | $217.10 | 2020-2022 | |
| Valeritas, INC. | $207.71 | 2019 | |
| Ibsa Pharma INC. | $162.43 | 2020-2023 | Tirosint, Licart |
| Astellas Pharma US INC | $162.42 | 2019-2020 | |
| Abbvie INC. | $158.01 | 2022-2025 | |
| Phathom Pharmaceuticals, INC. | $120.58 | 2023-2025 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $118.34 | 2019-2021 | |
| Nevro Corp. | $117.94 | 2021-2023 | Senza |
| Beta Bionics, INC. | $104.52 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Azurity Pharmaceuticals, INC. | $91.03 | 2023-2024 | Horizant, Edarbi, Horizant |
| Paratek Pharmaceuticals, INC. | $90.65 | 2022-2025 | Nuzyra |
| Kowa Pharmaceuticals America, INC. | $86.52 | 2019-2024 | Livalo |
| Globus Medical, INC. | $62.59 | 2025 | Senza |
| Companion Medical, INC. | $62.24 | 2019-2020 | |
| Embecta Corp. | $55.64 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Regeneron Healthcare Solutions, INC. | $50.44 | 2019-2023 | Evkeeza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.02 | 2019-2023 | Xifaxan |
| Radius Health, INC. | $48.61 | 2022-2023 | Tymlos |
| Arbor Pharmaceuticals, INC. | $47.95 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $47.35 | 2021 | |
| Horizon Therapeutics Plc | $45.20 | 2019-2020 | |
| Allergan, INC. | $44.83 | 2020 | |
| Sumitomo Pharma America, INC. | $43.95 | 2023-2025 | Gemtesa |
| Abiomed | $40.56 | 2024 | Impella |
| Sunovion Pharmaceuticals INC. | $40.53 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $37.27 | 2022 | |
| Medtronic, INC. | $34.38 | 2021-2023 | Arctic Front Advance |
| Insightec,INC | $34.21 | 2025 | Exablate |
| Sanofi Pasteur INC. | $33.72 | 2023 | |
| Madrigal Pharmaceuticals | $31.24 | 2025 | Rezdiffra |
| Scpharmaceuticals INC. | $30.10 | 2025 | |
| Cequr Corporation | $28.50 | 2021-2024 | Cequr Simplicity |
| Janssen Scientific Affairs, LLC | $27.01 | 2019 | |
| Axonics, INC. | $20.32 | 2023 | Axonics |
| Sequel Med Tech, LLC | $19.82 | 2025 | Twiist |
| Lifescan, INC. | $17.51 | 2022 | |
| Optinose US, INC. | $17.10 | 2022 | |
| Antares Pharma, INC. | $16.87 | 2020 | |
| Eisai INC. | $16.55 | 2022 | |
| Averitas Pharma INC. | $16.06 | 2025 | Qutenza |
| Almatica Pharma LLC | $14.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Kilo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.